Published in Women's Health Weekly, April 26th, 1999
In a study of 92 Icelandic women, the researchers, led by Kay Huebner, PhD, professor of microbiology and immunology at Jefferson Medical College and a member of Jefferson's Kimmel Cancer Center, showed reduced levels of Fhit, the protein for which FHIT encodes, both in women with sporadic breast cancer and those with hereditary breast cancer who carry a BRCA2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly